Prevalence of severe cardiovascular disease in patients with schizophrenia

J-C Marche1, A Bannay2, S Baillot2

  • 1Psychiatry and Clinical Psychology Service (G06), Psychotherapeutic Center of Nancy, 1, rue Dr-Archambault, BP 11010, 54521 Laxou cedex, France; University of Lorraine, Lorraine, France.

L'Encephale
|May 24, 2021
PubMed

Insights

Patients with schizophrenia experience severe cardiovascular disease (CVD) at younger ages. This study highlights the high prevalence of CVD risk factors in this population, emphasizing the need for early screening and intervention.

Area of Science:

  • Cardiology
  • Psychiatry
  • Public Health

Background:

  • Schizophrenia is associated with increased cardiovascular disease (CVD) risk.
  • Understanding the prevalence and early onset of severe CVD in schizophrenia patients is crucial for public health initiatives.

Purpose of the Study:

  • To determine the prevalence of severe cardiovascular disease (CVD) requiring hospitalization in patients diagnosed with schizophrenia in France.
  • To identify associated cardiovascular risk factors in this patient group.

Main Methods:

  • A retrospective study included 4424 patients hospitalized with schizophrenia in five French psychiatric hospitals in 2015.
  • Cardiovascular disease (CVD) was identified via ICD-10 codes for myocardial infarction, stroke, heart failure, coronary artery disease, or peripheral artery disease up to five years prior and three years after psychiatric hospitalization.
  • Prevalence of hypertension, obesity, and diabetes was recorded.

Main Results:

  • Overall, 4.6% of patients with schizophrenia were diagnosed with severe cardiovascular disease (CVD).
  • Specific CVD prevalence included coronary artery disease (2.1%), heart failure (1.9%), and stroke (1.1%).
  • High prevalence of risk factors was observed: hypertension (11.3%), obesity (9.7%), and diabetes (7.8%).

Conclusions:

  • Patients with schizophrenia develop severe cardiovascular disease (CVD) requiring hospitalization at an earlier age compared to the general population.
  • The high co-occurrence of CVD and risk factors underscores the need for proactive cardiovascular health management in schizophrenia care.
  • Early screening and management of CVD and its risk factors are essential to improve life expectancy and quality of life for individuals with schizophrenia.
Abstract

Related Concept Videos

Schizophrenia01:17

Schizophrenia

Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those...
387
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
141
Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
256
Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
218
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
105
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
113